Literature DB >> 21293250

Opioid facilitation of rewarding electrical brain stimulation is suppressed in rats with neuropathic pain.

Eric E Ewan1, Thomas J Martin.   

Abstract

INTRODUCTION: Opioids are powerful analgesics, but are also common drugs of abuse. Few studies have examined how neuropathic pain alters the pharmacology of opioids in modulating limbic pathways that underlie abuse liability.
METHODS: Rats with or without spinal nerve ligation (SNL) were implanted with electrodes into the left ventral tegmental area and trained to lever press for electrical stimulation. The effects of morphine, heroin, and cocaine on facilitating electrical stimulation of the ventral tegmental area and mechanical allodynia were assessed in SNL and control subjects.
RESULTS: Responding for electrical stimulation of the ventral tegmental area was similar in control and SNL rats. The frequency at which rats emitted 50% of maximal responding was 98.2 ± 5.1 (mean ± SEM) and 93.7 ± 2.8 Hz in control and SNL rats, respectively. Morphine reduced the frequency at which rats emitted 50% of maximal responding in control (maximal shift of 14.8 ± 3.1 Hz), but not SNL (2.3 ± 2.2 Hz) rats. Heroin was less potent in SNL rats, whereas cocaine produced similar shifts in control (42.3 ± 2.0 Hz) and SNL (37.5 ± 4.2 Hz) rats.
CONCLUSIONS: Nerve injury suppressed potentiation of electrical stimulation of the ventral tegmental area by opioids, suggesting that the positive reinforcing effects are diminished by chronic pain. Given concerns regarding prescription opioid abuse, developing strategies that assess both analgesia and abuse liability within the context of chronic pain may aid in determining which opioids are most suitable for treating chronic pain when abuse is a concern.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21293250      PMCID: PMC3073684          DOI: 10.1097/ALN.0b013e31820a4edb

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  23 in total

Review 1.  Pharmacology of opioid and nonopioid analgesics in chronic pain states.

Authors:  T J Martin; J C Eisenach
Journal:  J Pharmacol Exp Ther       Date:  2001-12       Impact factor: 4.030

2.  Plasmalemmal mu-opioid receptor distribution mainly in nondopaminergic neurons in the rat ventral tegmental area.

Authors:  M Garzón; V M Pickel
Journal:  Synapse       Date:  2001-09-15       Impact factor: 2.562

3.  The curve-shift paradigm in self-stimulation.

Authors:  E Miliaressis; P P Rompre; P Laviolette; L Philippe; D Coulombe
Journal:  Physiol Behav       Date:  1986

4.  Suppression of the morphine-induced rewarding effect and G-protein activation in the lower midbrain following nerve injury in the mouse: involvement of G-protein-coupled receptor kinase 2.

Authors:  S Ozaki; M Narita; M Narita; M Iino; K Miyoshi; T Suzuki
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

5.  An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat.

Authors:  Sun Ho Kim; Jin Mo Chung
Journal:  Pain       Date:  1992-09       Impact factor: 6.961

6.  Role of extracellular signal-regulated kinase in the ventral tegmental area in the suppression of the morphine-induced rewarding effect in mice with sciatic nerve ligation.

Authors:  Satoru Ozaki; Minoru Narita; Michiko Narita; Masahiko Ozaki; Junaidi Khotib; Tsutomu Suzuki
Journal:  J Neurochem       Date:  2004-03       Impact factor: 5.372

7.  Quantitative assessment of tactile allodynia in the rat paw.

Authors:  S R Chaplan; F W Bach; J W Pogrel; J M Chung; T L Yaksh
Journal:  J Neurosci Methods       Date:  1994-07       Impact factor: 2.390

8.  Suppression of the morphine-induced rewarding effect in the rat with neuropathic pain: implication of the reduction in mu-opioid receptor functions in the ventral tegmental area.

Authors:  Satoru Ozaki; Minoru Narita; Michiko Narita; Masahiko Iino; Junichi Sugita; Yumiko Matsumura; Tsutomu Suzuki
Journal:  J Neurochem       Date:  2002-09       Impact factor: 5.372

9.  Regulation of morphine antiallodynic efficacy by cholecystokinin in a model of neuropathic pain in rats.

Authors:  M L Nichols; D Bian; M H Ossipov; J Lai; F Porreca
Journal:  J Pharmacol Exp Ther       Date:  1995-12       Impact factor: 4.030

10.  Morphine-induced activation of A10 dopamine neurons in the rat.

Authors:  K Gysling; R Y Wang
Journal:  Brain Res       Date:  1983-10-24       Impact factor: 3.252

View more
  20 in total

1.  Rewarding electrical brain stimulation in rats after peripheral nerve injury: decreased facilitation by commonly abused prescription opioids.

Authors:  Eric E Ewan; Thomas J Martin
Journal:  Anesthesiology       Date:  2011-12       Impact factor: 7.892

Review 2.  Determinants of opioid abuse potential: Insights using intracranial self-stimulation.

Authors:  S Stevens Negus; Megan J Moerke
Journal:  Peptides       Date:  2018-11-01       Impact factor: 3.750

3.  The affective dimension of pain as a risk factor for drug and alcohol addiction.

Authors:  Dana M LeBlanc; M Adrienne McGinn; Christy A Itoga; Scott Edwards
Journal:  Alcohol       Date:  2015-05-01       Impact factor: 2.405

4.  Intracranial self-stimulation of the paraventricular nucleus of the hypothalamus: increased faciliation by morphine compared to cocaine.

Authors:  Eric E Ewan; Thomas J Martin
Journal:  Anesthesiology       Date:  2012-05       Impact factor: 7.892

Review 5.  Alcohol dependence as a chronic pain disorder.

Authors:  Mark Egli; George F Koob; Scott Edwards
Journal:  Neurosci Biobehav Rev       Date:  2012-09-11       Impact factor: 8.989

6.  Effects of paclitaxel on mechanical sensitivity and morphine reward in male and female C57Bl6 mice.

Authors:  Harshini Neelakantan; Sara Jane Ward; Ellen Ann Walker
Journal:  Exp Clin Psychopharmacol       Date:  2016-12       Impact factor: 3.157

7.  RGS9-2 Modulates Responses to Oxycodone in Pain-Free and Chronic Pain States.

Authors:  Sevasti Gaspari; Valeria Cogliani; Lefteris Manouras; Ethan M Anderson; Vasiliki Mitsi; Kleopatra Avrampou; Fiona B Carr; Venetia Zachariou
Journal:  Neuropsychopharmacology       Date:  2017-01-11       Impact factor: 7.853

Review 8.  Intracranial self-stimulation to evaluate abuse potential of drugs.

Authors:  S Stevens Negus; Laurence L Miller
Journal:  Pharmacol Rev       Date:  2014-07       Impact factor: 25.468

9.  Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria.

Authors:  Tarsis F Brust; Jenny Morgenweck; Susy A Kim; Jamie H Rose; Jason L Locke; Cullen L Schmid; Lei Zhou; Edward L Stahl; Michael D Cameron; Sarah M Scarry; Jeffrey Aubé; Sara R Jones; Thomas J Martin; Laura M Bohn
Journal:  Sci Signal       Date:  2016-11-29       Impact factor: 8.192

10.  Development of mechanical hypersensitivity in rats during heroin and ethanol dependence: alleviation by CRF₁ receptor antagonism.

Authors:  Scott Edwards; Leandro F Vendruscolo; Joel E Schlosburg; Kaushik K Misra; Sunmee Wee; Paula E Park; Gery Schulteis; George F Koob
Journal:  Neuropharmacology       Date:  2011-11-23       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.